The DOI matches its Crossref record.
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., & Zacny, V. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204860 · Cited by 588
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Narisawa‐Saito, M., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00546.x · Cited by 528
The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
Yim, E.-K., & Park, J.-S. (2005) · Cancer Research and Treatment · doi:10.4143/crt.2005.37.6.319 · Cited by 453
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428
“Another example of a virusencoded inhibitor of IRF9 is the E7 protein of HPV16, which has been shown to bind to IRF9, preventing its association with STAT1–STAT2 heterodimers [143].”
BackgroundInterferons and viruses: an evolutionary arms race of molecular interactions
Hoffmann, H.-H., Schneider, W. M., & Rice, C. M. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.004 · Cited by 410
The papillomavirus E7 proteins
Roman, A., & Munger, K. (2013) · Virology · doi:10.1016/j.virol.2013.04.013 · Cited by 409
Prevention of cervical cancer through papillomavirus vaccination
Frazer, I. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1260 · Cited by 402
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity
Hebner, C. M., & Laimins, L. A. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.488 · Cited by 401
The human papillomavirus E7 oncoprotein
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virology · doi:10.1016/j.virol.2008.10.006 · Cited by 391
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
Bouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M., & Haller, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1371-1377.2001 · Cited by 381
Durfee, L. A., Lyon, N., Seo, K., & Huibregtse, J. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.002 · Cited by 358
García-Sastre, A. (2001) · Virology · doi:10.1006/viro.2000.0756 · Cited by 321
Oncogenic activities of human papillomaviruses
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.06.008 · Cited by 321
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
Park, J.-S., Kim, E.-J., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S.-J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 285
Chang, Y. E., & Laimins, L. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4174-4182.2000 · Cited by 284
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Cell-Mediated Immune Response to Human Papillomavirus Infection
Scott, M., Nakagawa, M., & Moscicki, A.-B. (2001) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.2.209-220.2001 · Cited by 273
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation
Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0858 · Cited by 252
Proteinase 2AproIs Essential for Enterovirus Replication in Type I Interferon-Treated Cells
Morrison, J. M., & Racaniello, V. R. (2009) · Journal of Virology · doi:10.1128/jvi.02177-08 · Cited by 51
Metadata
- Authors
- Barnard, P., & McMillan, N. A. J.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1999-07
- Volume
- 259
- Issue
- 2
- Pages
- 305-313
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2009506842
- Cited by
- 227
- References
- 0
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.